)
)
Black Diamond Therapeutics Investor Relations Material
Latest events
Study Update
Black Diamond Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Black Diamond Therapeutics Inc
Access all reports
Black Diamond Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing precision oncology therapies. The company specializes in "MasterKey" therapies, designed to target a broad range of genetically defined tumors. These therapies aim to overcome resistance to treatment, minimize toxicities associated with targeting healthy cells, and penetrate the blood-brain barrier to address central nervous system (CNS) diseases. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Black Diamond Therapeutics Inc
Study Update
Black Diamond Therapeutics Inc
Corporate Presentation
Black Diamond Therapeutics Inc
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
BDTX
Country
🇺🇸 United States